Metabolomics	B:C0870883
analysis	O
of	O
anaphylactoid	O
reaction	I:C0340865
reveals	O
its	O
mechanism	O
in	O
a	O
rat	O
model	O
Anaphylactoid	O
reactions	I:C0340865
,	O
accounting	O
for	O
more	O
than	O
77	O
%	O
of	O
all	O
immune	O
-	I:C0301918
mediated	I:C0301918
immediate	I:C0301918
hypersensitivity	I:C0301918
reactions	I:C0301918
,	O
have	O
become	O
a	O
serious	O
threat	O
to	O
public	O
health	I:C0699943
,	O
but	O
their	O
effect	O
mechanism	O
is	O
not	O
clear	O
and	O
diagnostic	O
tests	I:C0086143
are	O
limited	O
.	O

Metabolomics	O
analysis	B:C0936012
of	O
anaphylactoid	O
reaction	I:C0340865
reveals	O
its	O
mechanism	O
in	O
a	O
rat	O
model	O
Anaphylactoid	O
reactions	I:C0340865
,	O
accounting	O
for	O
more	O
than	O
77	O
%	O
of	O
all	O
immune	O
-	I:C0301918
mediated	I:C0301918
immediate	I:C0301918
hypersensitivity	I:C0301918
reactions	I:C0301918
,	O
have	O
become	O
a	O
serious	O
threat	O
to	O
public	O
health	I:C0699943
,	O
but	O
their	O
effect	O
mechanism	O
is	O
not	O
clear	O
and	O
diagnostic	O
tests	I:C0086143
are	O
limited	O
.	O

Metabolomics	O
analysis	O
of	O
anaphylactoid	B:C0340865
reaction	I:C0340865
reveals	O
its	O
mechanism	O
in	O
a	O
rat	O
model	O
Anaphylactoid	O
reactions	I:C0340865
,	O
accounting	O
for	O
more	O
than	O
77	O
%	O
of	O
all	O
immune	O
-	I:C0301918
mediated	I:C0301918
immediate	I:C0301918
hypersensitivity	I:C0301918
reactions	I:C0301918
,	O
have	O
become	O
a	O
serious	O
threat	O
to	O
public	O
health	I:C0699943
,	O
but	O
their	O
effect	O
mechanism	O
is	O
not	O
clear	O
and	O
diagnostic	O
tests	I:C0086143
are	O
limited	O
.	O

Metabolomics	O
analysis	O
of	O
anaphylactoid	O
reaction	I:C0340865
reveals	O
its	O
mechanism	O
in	O
a	O
rat	B:C0034721
model	O
Anaphylactoid	O
reactions	I:C0340865
,	O
accounting	O
for	O
more	O
than	O
77	O
%	O
of	O
all	O
immune	O
-	I:C0301918
mediated	I:C0301918
immediate	I:C0301918
hypersensitivity	I:C0301918
reactions	I:C0301918
,	O
have	O
become	O
a	O
serious	O
threat	O
to	O
public	O
health	I:C0699943
,	O
but	O
their	O
effect	O
mechanism	O
is	O
not	O
clear	O
and	O
diagnostic	O
tests	I:C0086143
are	O
limited	O
.	O

Metabolomics	O
analysis	O
of	O
anaphylactoid	O
reaction	I:C0340865
reveals	O
its	O
mechanism	O
in	O
a	O
rat	O
model	B:C0599779
Anaphylactoid	O
reactions	I:C0340865
,	O
accounting	O
for	O
more	O
than	O
77	O
%	O
of	O
all	O
immune	O
-	I:C0301918
mediated	I:C0301918
immediate	I:C0301918
hypersensitivity	I:C0301918
reactions	I:C0301918
,	O
have	O
become	O
a	O
serious	O
threat	O
to	O
public	O
health	I:C0699943
,	O
but	O
their	O
effect	O
mechanism	O
is	O
not	O
clear	O
and	O
diagnostic	O
tests	I:C0086143
are	O
limited	O
.	O

Metabolomics	O
analysis	O
of	O
anaphylactoid	O
reaction	I:C0340865
reveals	O
its	O
mechanism	O
in	O
a	O
rat	O
model	O
Anaphylactoid	B:C0340865
reactions	I:C0340865
,	O
accounting	O
for	O
more	O
than	O
77	O
%	O
of	O
all	O
immune	O
-	I:C0301918
mediated	I:C0301918
immediate	I:C0301918
hypersensitivity	I:C0301918
reactions	I:C0301918
,	O
have	O
become	O
a	O
serious	O
threat	O
to	O
public	O
health	I:C0699943
,	O
but	O
their	O
effect	O
mechanism	O
is	O
not	O
clear	O
and	O
diagnostic	O
tests	I:C0086143
are	O
limited	O
.	O

Metabolomics	O
analysis	O
of	O
anaphylactoid	O
reaction	I:C0340865
reveals	O
its	O
mechanism	O
in	O
a	O
rat	O
model	O
Anaphylactoid	O
reactions	I:C0340865
,	O
accounting	O
for	O
more	O
than	O
77	O
%	O
of	O
all	O
immune	B:C0301918
-	I:C0301918
mediated	I:C0301918
immediate	I:C0301918
hypersensitivity	I:C0301918
reactions	I:C0301918
,	O
have	O
become	O
a	O
serious	O
threat	O
to	O
public	O
health	I:C0699943
,	O
but	O
their	O
effect	O
mechanism	O
is	O
not	O
clear	O
and	O
diagnostic	O
tests	I:C0086143
are	O
limited	O
.	O

Metabolomics	O
analysis	O
of	O
anaphylactoid	O
reaction	I:C0340865
reveals	O
its	O
mechanism	O
in	O
a	O
rat	O
model	O
Anaphylactoid	O
reactions	I:C0340865
,	O
accounting	O
for	O
more	O
than	O
77	O
%	O
of	O
all	O
immune	O
-	I:C0301918
mediated	I:C0301918
immediate	I:C0301918
hypersensitivity	I:C0301918
reactions	I:C0301918
,	O
have	O
become	O
a	O
serious	O
threat	O
to	O
public	B:C0699943
health	I:C0699943
,	O
but	O
their	O
effect	O
mechanism	O
is	O
not	O
clear	O
and	O
diagnostic	O
tests	I:C0086143
are	O
limited	O
.	O

Metabolomics	O
analysis	O
of	O
anaphylactoid	O
reaction	I:C0340865
reveals	O
its	O
mechanism	O
in	O
a	O
rat	O
model	O
Anaphylactoid	O
reactions	I:C0340865
,	O
accounting	O
for	O
more	O
than	O
77	O
%	O
of	O
all	O
immune	O
-	I:C0301918
mediated	I:C0301918
immediate	I:C0301918
hypersensitivity	I:C0301918
reactions	I:C0301918
,	O
have	O
become	O
a	O
serious	O
threat	O
to	O
public	O
health	I:C0699943
,	O
but	O
their	O
effect	O
mechanism	O
is	O
not	O
clear	O
and	O
diagnostic	B:C0086143
tests	I:C0086143
are	O
limited	O
.	O

Comprehensive	O
metabolite	B:C0870883
analysis	O
may	O
reveal	O
the	O
anaphylactoid	O
effect	O
mechanism	O
systematically	O
and	O
provide	O
reference	O
for	O
future	O
diagnostic	O
purposes	O
.	O

Comprehensive	O
metabolite	O
analysis	B:C0936012
may	O
reveal	O
the	O
anaphylactoid	O
effect	O
mechanism	O
systematically	O
and	O
provide	O
reference	O
for	O
future	O
diagnostic	O
purposes	O
.	O

Plasma	B:C0032105
from	O
Brown	O
Norway	I:C0034700
rats	I:C0034700
given	O
intravenous	O
injection	O
of	O
saline	O
,	O
compound	O
48/80	I:C0009574
(	O
2.5	O
mL	O
/	O
kg	O
)	O
or	O
ovalbumin	O
(	O
20	O
mL	O
/	O
kg	O
)	O
in	O
20	O
s	O
for	O
the	O
first	O
time	O
was	O
used	O
to	O
study	O
the	O
effect	O
mechanism	O
of	O
anaphylactoid	O
reactions	I:C0340865
through	O
metabolomics	O
(	O
UPLC	O
-	I:C0599748
qTOF-MS	I:C0599748
/	I:C0599748
MS	I:C0599748
)	O
.	O

Plasma	O
from	O
Brown	B:C0034700
Norway	I:C0034700
rats	I:C0034700
given	O
intravenous	O
injection	O
of	O
saline	O
,	O
compound	O
48/80	I:C0009574
(	O
2.5	O
mL	O
/	O
kg	O
)	O
or	O
ovalbumin	O
(	O
20	O
mL	O
/	O
kg	O
)	O
in	O
20	O
s	O
for	O
the	O
first	O
time	O
was	O
used	O
to	O
study	O
the	O
effect	O
mechanism	O
of	O
anaphylactoid	O
reactions	I:C0340865
through	O
metabolomics	O
(	O
UPLC	O
-	I:C0599748
qTOF-MS	I:C0599748
/	I:C0599748
MS	I:C0599748
)	O
.	O

Plasma	O
from	O
Brown	O
Norway	I:C0034700
rats	I:C0034700
given	O
intravenous	O
injection	O
of	O
saline	O
,	O
compound	B:C0009574
48/80	I:C0009574
(	O
2.5	O
mL	O
/	O
kg	O
)	O
or	O
ovalbumin	O
(	O
20	O
mL	O
/	O
kg	O
)	O
in	O
20	O
s	O
for	O
the	O
first	O
time	O
was	O
used	O
to	O
study	O
the	O
effect	O
mechanism	O
of	O
anaphylactoid	O
reactions	I:C0340865
through	O
metabolomics	O
(	O
UPLC	O
-	I:C0599748
qTOF-MS	I:C0599748
/	I:C0599748
MS	I:C0599748
)	O
.	O

Plasma	O
from	O
Brown	O
Norway	I:C0034700
rats	I:C0034700
given	O
intravenous	O
injection	O
of	O
saline	O
,	O
compound	O
48/80	I:C0009574
(	O
2.5	O
mL	O
/	O
kg	O
)	O
or	O
ovalbumin	B:C0029923
(	O
20	O
mL	O
/	O
kg	O
)	O
in	O
20	O
s	O
for	O
the	O
first	O
time	O
was	O
used	O
to	O
study	O
the	O
effect	O
mechanism	O
of	O
anaphylactoid	O
reactions	I:C0340865
through	O
metabolomics	O
(	O
UPLC	O
-	I:C0599748
qTOF-MS	I:C0599748
/	I:C0599748
MS	I:C0599748
)	O
.	O

Plasma	O
from	O
Brown	O
Norway	I:C0034700
rats	I:C0034700
given	O
intravenous	O
injection	O
of	O
saline	O
,	O
compound	O
48/80	I:C0009574
(	O
2.5	O
mL	O
/	O
kg	O
)	O
or	O
ovalbumin	O
(	O
20	O
mL	O
/	O
kg	O
)	O
in	O
20	O
s	O
for	O
the	O
first	O
time	O
was	O
used	O
to	O
study	B:C2603343
the	O
effect	O
mechanism	O
of	O
anaphylactoid	O
reactions	I:C0340865
through	O
metabolomics	O
(	O
UPLC	O
-	I:C0599748
qTOF-MS	I:C0599748
/	I:C0599748
MS	I:C0599748
)	O
.	O

Plasma	O
from	O
Brown	O
Norway	I:C0034700
rats	I:C0034700
given	O
intravenous	O
injection	O
of	O
saline	O
,	O
compound	O
48/80	I:C0009574
(	O
2.5	O
mL	O
/	O
kg	O
)	O
or	O
ovalbumin	O
(	O
20	O
mL	O
/	O
kg	O
)	O
in	O
20	O
s	O
for	O
the	O
first	O
time	O
was	O
used	O
to	O
study	O
the	O
effect	O
mechanism	O
of	O
anaphylactoid	B:C0340865
reactions	I:C0340865
through	O
metabolomics	O
(	O
UPLC	O
-	I:C0599748
qTOF-MS	I:C0599748
/	I:C0599748
MS	I:C0599748
)	O
.	O

Plasma	O
from	O
Brown	O
Norway	I:C0034700
rats	I:C0034700
given	O
intravenous	O
injection	O
of	O
saline	O
,	O
compound	O
48/80	I:C0009574
(	O
2.5	O
mL	O
/	O
kg	O
)	O
or	O
ovalbumin	O
(	O
20	O
mL	O
/	O
kg	O
)	O
in	O
20	O
s	O
for	O
the	O
first	O
time	O
was	O
used	O
to	O
study	O
the	O
effect	O
mechanism	O
of	O
anaphylactoid	O
reactions	I:C0340865
through	O
metabolomics	B:C0870883
(	O
UPLC	O
-	I:C0599748
qTOF-MS	I:C0599748
/	I:C0599748
MS	I:C0599748
)	O
.	O

Plasma	O
from	O
Brown	O
Norway	I:C0034700
rats	I:C0034700
given	O
intravenous	O
injection	O
of	O
saline	O
,	O
compound	O
48/80	I:C0009574
(	O
2.5	O
mL	O
/	O
kg	O
)	O
or	O
ovalbumin	O
(	O
20	O
mL	O
/	O
kg	O
)	O
in	O
20	O
s	O
for	O
the	O
first	O
time	O
was	O
used	O
to	O
study	O
the	O
effect	O
mechanism	O
of	O
anaphylactoid	O
reactions	I:C0340865
through	O
metabolomics	O
(	O
UPLC	B:C0599748
-	I:C0599748
qTOF-MS	I:C0599748
/	I:C0599748
MS	I:C0599748
)	O
.	O

Metabolomics	B:C0870883
integrated	O
with	O
proteomics	O
data	I:C0242356
were	O
used	O
to	O
analyze	O
the	O
anaphylactoid	O
pathways	O
by	O
MetaboAnalyst	O
followed	O
by	O
integrated	O
pathway	O
analysis	I:C0868995
.	O

Metabolomics	O
integrated	O
with	O
proteomics	B:C0242356
data	I:C0242356
were	O
used	O
to	O
analyze	O
the	O
anaphylactoid	O
pathways	O
by	O
MetaboAnalyst	O
followed	O
by	O
integrated	O
pathway	O
analysis	I:C0868995
.	O

Metabolomics	O
integrated	O
with	O
proteomics	O
data	I:C0242356
were	O
used	O
to	O
analyze	B:C0936012
the	O
anaphylactoid	O
pathways	O
by	O
MetaboAnalyst	O
followed	O
by	O
integrated	O
pathway	O
analysis	I:C0868995
.	O

Metabolomics	O
integrated	O
with	O
proteomics	O
data	I:C0242356
were	O
used	O
to	O
analyze	O
the	O
anaphylactoid	O
pathways	B:C1704259
by	O
MetaboAnalyst	O
followed	O
by	O
integrated	O
pathway	O
analysis	I:C0868995
.	O

Metabolomics	O
integrated	O
with	O
proteomics	O
data	I:C0242356
were	O
used	O
to	O
analyze	O
the	O
anaphylactoid	O
pathways	O
by	O
MetaboAnalyst	B:C0037589
followed	O
by	O
integrated	O
pathway	O
analysis	I:C0868995
.	O

Metabolomics	O
integrated	O
with	O
proteomics	O
data	I:C0242356
were	O
used	O
to	O
analyze	O
the	O
anaphylactoid	O
pathways	O
by	O
MetaboAnalyst	O
followed	O
by	O
integrated	O
pathway	B:C0868995
analysis	I:C0868995
.	O

Thirty	O
metabolites	B:C0870883
were	O
identified	O
through	O
the	O
METLIN	O
database	I:C0242356
by	O
MS	O
/	I:C0599748
MS	I:C0599748
and	O
18	O
of	O
them	O
were	O
confirmed	O
by	O
authentic	O
standards	O
.	O

Thirty	O
metabolites	O
were	O
identified	O
through	O
the	O
METLIN	B:C0242356
database	I:C0242356
by	O
MS	O
/	I:C0599748
MS	I:C0599748
and	O
18	O
of	O
them	O
were	O
confirmed	O
by	O
authentic	O
standards	O
.	O

Thirty	O
metabolites	O
were	O
identified	O
through	O
the	O
METLIN	O
database	I:C0242356
by	O
MS	B:C0599748
/	I:C0599748
MS	I:C0599748
and	O
18	O
of	O
them	O
were	O
confirmed	O
by	O
authentic	O
standards	O
.	O

The	O
results	O
showed	O
that	O
adenosine	B:C0001443
,	O
histamine	O
,	O
N	O
-	I:C0067730
acetylhistamine	I:C0067730
,	O
N(α	O
)	I:C0061063
-γ-	I:C0061063
glutamylhistamine	I:C0061063
,	O
malate	O
and	O
xanthine	O
are	O
important	O
indices	O
for	O
anaphylactoid	O
reactions	I:C0340865
.	O

The	O
results	O
showed	O
that	O
adenosine	O
,	O
histamine	B:C0019588
,	O
N	O
-	I:C0067730
acetylhistamine	I:C0067730
,	O
N(α	O
)	I:C0061063
-γ-	I:C0061063
glutamylhistamine	I:C0061063
,	O
malate	O
and	O
xanthine	O
are	O
important	O
indices	O
for	O
anaphylactoid	O
reactions	I:C0340865
.	O

The	O
results	O
showed	O
that	O
adenosine	O
,	O
histamine	O
,	O
N	B:C0067730
-	I:C0067730
acetylhistamine	I:C0067730
,	O
N(α	O
)	I:C0061063
-γ-	I:C0061063
glutamylhistamine	I:C0061063
,	O
malate	O
and	O
xanthine	O
are	O
important	O
indices	O
for	O
anaphylactoid	O
reactions	I:C0340865
.	O

The	O
results	O
showed	O
that	O
adenosine	O
,	O
histamine	O
,	O
N	O
-	I:C0067730
acetylhistamine	I:C0067730
,	O
N(α	B:C0061063
)	I:C0061063
-γ-	I:C0061063
glutamylhistamine	I:C0061063
,	O
malate	O
and	O
xanthine	O
are	O
important	O
indices	O
for	O
anaphylactoid	O
reactions	I:C0340865
.	O

The	O
results	O
showed	O
that	O
adenosine	O
,	O
histamine	O
,	O
N	O
-	I:C0067730
acetylhistamine	I:C0067730
,	O
N(α	O
)	I:C0061063
-γ-	I:C0061063
glutamylhistamine	I:C0061063
,	O
malate	B:C0220873
and	O
xanthine	O
are	O
important	O
indices	O
for	O
anaphylactoid	O
reactions	I:C0340865
.	O

The	O
results	O
showed	O
that	O
adenosine	O
,	O
histamine	O
,	O
N	O
-	I:C0067730
acetylhistamine	I:C0067730
,	O
N(α	O
)	I:C0061063
-γ-	I:C0061063
glutamylhistamine	I:C0061063
,	O
malate	O
and	O
xanthine	B:C0043314
are	O
important	O
indices	O
for	O
anaphylactoid	O
reactions	I:C0340865
.	O

The	O
results	O
showed	O
that	O
adenosine	O
,	O
histamine	O
,	O
N	O
-	I:C0067730
acetylhistamine	I:C0067730
,	O
N(α	O
)	I:C0061063
-γ-	I:C0061063
glutamylhistamine	I:C0061063
,	O
malate	O
and	O
xanthine	O
are	O
important	O
indices	O
for	O
anaphylactoid	B:C0340865
reactions	I:C0340865
.	O

It	O
could	O
be	O
concluded	O
that	O
the	O
effect	O
mechanism	O
is	O
mainly	O
composed	O
of	O
histidine	B:C1156823
metabolism	I:C1156823
,	O
arachidonic	O
acid	I:C1158360
metabolism	I:C1158360
,	O
energy	O
metabolism	I:C0014272
,	O
purine	O
metabolism	O
and	O
other	O
small	O
molecules	O
through	O
30	O
metabolites	O
.	O

It	O
could	O
be	O
concluded	O
that	O
the	O
effect	O
mechanism	O
is	O
mainly	O
composed	O
of	O
histidine	O
metabolism	I:C1156823
,	O
arachidonic	B:C1158360
acid	I:C1158360
metabolism	I:C1158360
,	O
energy	O
metabolism	I:C0014272
,	O
purine	O
metabolism	O
and	O
other	O
small	O
molecules	O
through	O
30	O
metabolites	O
.	O

It	O
could	O
be	O
concluded	O
that	O
the	O
effect	O
mechanism	O
is	O
mainly	O
composed	O
of	O
histidine	O
metabolism	I:C1156823
,	O
arachidonic	O
acid	I:C1158360
metabolism	I:C1158360
,	O
energy	B:C0014272
metabolism	I:C0014272
,	O
purine	O
metabolism	O
and	O
other	O
small	O
molecules	O
through	O
30	O
metabolites	O
.	O

It	O
could	O
be	O
concluded	O
that	O
the	O
effect	O
mechanism	O
is	O
mainly	O
composed	O
of	O
histidine	O
metabolism	I:C1156823
,	O
arachidonic	O
acid	I:C1158360
metabolism	I:C1158360
,	O
energy	O
metabolism	I:C0014272
,	O
purine	O
metabolism	O
and	O
other	O
small	O
molecules	O
through	O
30	O
metabolites	B:C0870883
.	O

Multiple	O
linear	O
regression	O
analysis	O
indicated	B:C1444656
that	O
not	O
only	O
histamine	O
but	O
also	O
N(	O
α	I:C0061063
)	I:C0061063
-	I:C0061063
γ-	I:C0061063
glutamylhistamine	I:C0061063
and	O
arachidonic	O
acid	I:C0003695
could	O
be	O
used	O
to	O
evaluate	O
anaphylactoid	O
symptoms	O
of	O
animals	O
.	O

Multiple	O
linear	O
regression	O
analysis	O
indicated	O
that	O
not	O
only	O
histamine	B:C0019588
but	O
also	O
N(	O
α	I:C0061063
)	I:C0061063
-	I:C0061063
γ-	I:C0061063
glutamylhistamine	I:C0061063
and	O
arachidonic	O
acid	I:C0003695
could	O
be	O
used	O
to	O
evaluate	O
anaphylactoid	O
symptoms	O
of	O
animals	O
.	O

Multiple	O
linear	O
regression	O
analysis	O
indicated	O
that	O
not	O
only	O
histamine	O
but	O
also	O
N(	B:C0061063
α	I:C0061063
)	I:C0061063
-	I:C0061063
γ-	I:C0061063
glutamylhistamine	I:C0061063
and	O
arachidonic	O
acid	I:C0003695
could	O
be	O
used	O
to	O
evaluate	O
anaphylactoid	O
symptoms	O
of	O
animals	O
.	O

Multiple	O
linear	O
regression	O
analysis	O
indicated	O
that	O
not	O
only	O
histamine	O
but	O
also	O
N(	O
α	I:C0061063
)	I:C0061063
-	I:C0061063
γ-	I:C0061063
glutamylhistamine	I:C0061063
and	O
arachidonic	B:C0003695
acid	I:C0003695
could	O
be	O
used	O
to	O
evaluate	O
anaphylactoid	O
symptoms	O
of	O
animals	O
.	O

Multiple	O
linear	O
regression	O
analysis	O
indicated	O
that	O
not	O
only	O
histamine	O
but	O
also	O
N(	O
α	I:C0061063
)	I:C0061063
-	I:C0061063
γ-	I:C0061063
glutamylhistamine	I:C0061063
and	O
arachidonic	O
acid	I:C0003695
could	O
be	O
used	O
to	O
evaluate	O
anaphylactoid	O
symptoms	B:C1457887
of	O
animals	O
.	O

Multiple	O
linear	O
regression	O
analysis	O
indicated	O
that	O
not	O
only	O
histamine	O
but	O
also	O
N(	O
α	I:C0061063
)	I:C0061063
-	I:C0061063
γ-	I:C0061063
glutamylhistamine	I:C0061063
and	O
arachidonic	O
acid	I:C0003695
could	O
be	O
used	O
to	O
evaluate	O
anaphylactoid	O
symptoms	O
of	O
animals	B:C0003062
.	O

Furthermore	O
,	O
the	O
citrate	B:C1516586
cycle	I:C1516586
,	O
histidine	O
metabolism	I:C1156823
and	O
arachidonic	O
acid	I:C1158360
metabolism	I:C1158360
could	O
be	O
the	O
main	O
pathways	O
of	O
anaphylactoid	O
reactions	I:C0340865
as	O
determined	O
by	O
MetaboAnalyst	O
.	O

Furthermore	O
,	O
the	O
citrate	O
cycle	I:C1516586
,	O
histidine	B:C1156823
metabolism	I:C1156823
and	O
arachidonic	O
acid	I:C1158360
metabolism	I:C1158360
could	O
be	O
the	O
main	O
pathways	O
of	O
anaphylactoid	O
reactions	I:C0340865
as	O
determined	O
by	O
MetaboAnalyst	O
.	O

Furthermore	O
,	O
the	O
citrate	O
cycle	I:C1516586
,	O
histidine	O
metabolism	I:C1156823
and	O
arachidonic	B:C1158360
acid	I:C1158360
metabolism	I:C1158360
could	O
be	O
the	O
main	O
pathways	O
of	O
anaphylactoid	O
reactions	I:C0340865
as	O
determined	O
by	O
MetaboAnalyst	O
.	O

Furthermore	O
,	O
the	O
citrate	O
cycle	I:C1516586
,	O
histidine	O
metabolism	I:C1156823
and	O
arachidonic	O
acid	I:C1158360
metabolism	I:C1158360
could	O
be	O
the	O
main	O
pathways	B:C1704259
of	O
anaphylactoid	O
reactions	I:C0340865
as	O
determined	O
by	O
MetaboAnalyst	O
.	O

Furthermore	O
,	O
the	O
citrate	O
cycle	I:C1516586
,	O
histidine	O
metabolism	I:C1156823
and	O
arachidonic	O
acid	I:C1158360
metabolism	I:C1158360
could	O
be	O
the	O
main	O
pathways	O
of	O
anaphylactoid	B:C0340865
reactions	I:C0340865
as	O
determined	O
by	O
MetaboAnalyst	O
.	O

Furthermore	O
,	O
the	O
citrate	O
cycle	I:C1516586
,	O
histidine	O
metabolism	I:C1156823
and	O
arachidonic	O
acid	I:C1158360
metabolism	I:C1158360
could	O
be	O
the	O
main	O
pathways	O
of	O
anaphylactoid	O
reactions	I:C0340865
as	O
determined	O
by	O
MetaboAnalyst	B:C0037589
.	O

The	O
results	O
may	O
provide	O
a	O
reference	B:C1514811
to	O
improve	O
diagnostic	O
accuracy	O
and	O
predict	O
and	O
monitor	O
treatment	O
efficacy	O
in	O
anaphylactoid	O
reactions	I:C0340865
in	O
the	O
clinical	O
setting	O
.	O

The	O
results	O
may	O
provide	O
a	O
reference	O
to	O
improve	B:C0184511
diagnostic	O
accuracy	O
and	O
predict	O
and	O
monitor	O
treatment	O
efficacy	O
in	O
anaphylactoid	O
reactions	I:C0340865
in	O
the	O
clinical	O
setting	O
.	O

The	O
results	O
may	O
provide	O
a	O
reference	O
to	O
improve	O
diagnostic	O
accuracy	O
and	O
predict	O
and	O
monitor	O
treatment	O
efficacy	O
in	O
anaphylactoid	B:C0340865
reactions	I:C0340865
in	O
the	O
clinical	O
setting	O
.	O

